PFE

2024Q2BMO

Pfizer Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-07-30 · Fiscal end 2024-06-30 · Features as of 2024-07-29

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS0.46
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.7%
IV front—
P/C full—
P/C front—
Features as of2024-07-29

Run-up

Close—
Ret 5d+3.8%
Ret 10d+5.6%
Ret 20d+9.8%
Ret 30d+11.1%

Post-Earnings Data

Results & reaction

Print

Actual EPS
0.60Beat
Estimated EPS0.46
Actual revenue
13.3B
Surprise %+30.4%
Beat / missBeat
Beat streak 44
Beat streak 88

Reaction

1-day stock reaction+1.2%
Implied vs actual

Implied 1.7%Actual 0.9%

Gap reaction+0.9%
Day result+2.2%
Next-day upYes
Realized / IV0.54×

Post tape

Post 5d-6.6%
Post 10d-8.1%
Post volume89.9M
Vol ×10d2.42×
Vol ×20d2.76×
Post range5.7%